Patient have 1-2 PI-RADS 3-5 lesion/lesions in biparametric prostate MRI, with no ISUP 2-5 prostate cancer in an initial systematic or lesion-targeted (at least two biopsy cores per lesion) biopsy
Prostate biopsies can be taken via transrectal approach in an outpatient clinic
An estimated life expentancy exceeding 10 years
The patient is cooperative, fluent in Finnish and understands the significance of the study
The patient signs an informed consent form approved by the ethics committee.
You may not be if
The patient had undergone prostate biopsies prior to the biopsies that led to recruitment for the current study.
Seriuos infectious or non-infectious complication after initial biopsy
Deep immunosuppression due to organ transplant, hematologic disease, or related causes.
Any treatment given for prostate cancer diagnosed in initial biopsy
Hip prosthesis or any other object in the pelvic area that affects high-quality MRI
Claustrophobia or other absolute or relative contraindication for high-quality MRI
Clareo Health | Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging
